🔎 Trials Near Me

Akèy › Limfòm Non-Hodgkin › Wisconsin

Etid klinik pou Limfòm Non-Hodgkin nan Wisconsin

20 etid pou Limfòm Non-Hodgkin ap chèche patisipan nan sit nan Wisconsin.

Vil nan Wisconsin

Tèks ofisyèl etid la (Anglè)

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Children's Hospital of Wisconsin, Milwaukee
Ap rekriteEtid obsèvasyon
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Aurora Cancer Care - Burlington, Burlington
  • Aurora Health Care - Germantown Health Center, Germantown
  • Aurora Cancer Care - Grafton, Grafton
  • ak 13 plis
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteFaz 1
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05798897

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  • Research Site, Milwaukee
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 a 81 · Tout sèks · Mizajou Aug 6, 2026 · NCT05990465

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06116110

DALY II USA/ MB-CART2019.1 for DLBCL

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Wisconsin - Madison, Madison
  • Children's Hospital of Wisconsin, Milwaukee
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Aspirus Langlade Hospital, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Saint Elizabeth Hospital, Appleton
  • ak 61 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT06876662

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT06876649

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

  • Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Feb 23, 2026 · NCT04186520

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • The Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Milwaukee
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteFaz 1
7 Months – 21 Years · Tout sèks · Mizajou Oct 16, 2025 · NCT02508038

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.